AGENDA
Wednesday, February 7, 2024
1 – 2:30 p.m. – Registration, Exhibits, Ancillary Events
2:30 – 2:35 p.m. – Introduction
2:35 – 3:20 p.m. – How to best incorporate CAR T and new targeted immunotherapy in DLBCL
3:20 – 4:05 p.m. – Management of newly diagnosed and relapsed Multiple Myeloma in 2024
4:05 – 4:20 p.m. – Break, Exhibits
4:20 – 5:05 p.m. – Emerging induction and consolidation regimens in Acute Lymphoblastic Leukemia
5:05 – 5:50 p.m. – Latest advancements in targeted therapy in Acute Myeloid Leukemia
5:50 – 7 p.m. – Exhibits, Ancillary Events
1 – 2:30 p.m. – Registration, Exhibits, Ancillary Events
2:30 – 2:35 p.m. – Introduction
2:35 – 3:20 p.m. – How to best incorporate CAR T and new targeted immunotherapy in DLBCL
3:20 – 4:05 p.m. – Management of newly diagnosed and relapsed Multiple Myeloma in 2024
4:05 – 4:20 p.m. – Break, Exhibits
4:20 – 5:05 p.m. – Emerging induction and consolidation regimens in Acute Lymphoblastic Leukemia
5:05 – 5:50 p.m. – Latest advancements in targeted therapy in Acute Myeloid Leukemia
5:50 – 7 p.m. – Exhibits, Ancillary Events
SERIES COURSE CHAIR
VK Gadi, MD, PhD
Professor and Director, Medical Oncology
Deputy Director
University of Illinois Cancer Center
Chicago, IL
Professor and Director, Medical Oncology
Deputy Director
University of Illinois Cancer Center
Chicago, IL
CO-CHAIR
Matias E. Sanchez, MD
Assistant Professor Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Assistant Professor Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
FACULTY
Carlos Galvez, MD
University of Illinois Cancer Center
Chicago, IL
University of Illinois Cancer Center
Chicago, IL
John Quigley, MD
University of Illinois Cancer Center
Chicago, IL
University of Illinois Cancer Center
Chicago, IL
Noah Birch, MD
University of Illinois Cancer Center
Chicago, IL
University of Illinois Cancer Center
Chicago, IL